West Pharmaceutical Services | WST - Interest Expense On Debt

Stock Price
306.16
Daily Change
-3.54 -1.14%
Monthly
23.94%
Yearly
42.70%
Q2 Forecast
299.61

West Pharmaceutical Services reported $1.9M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Align Technology USD 2M 660K Mar/2023
Avanos Medical USD 1.9M 100K Dec/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Cerus USD 2.33M 96K Jun/2024
Charles River Laboratories USD 23.78M 1.63M Dec/2025
Cooper Companies USD 22.4M 2M Dec/2025
Dentsply International USD 22M 1000K Dec/2025
Haemonetics USD 7.21M 3.14M Sep/2025
ICU Medical USD 20.64M 21.39M Dec/2025
Insulet USD 9.2M 2.2M Dec/2025
Integra LifeSciences USD 23.67M 953K Dec/2025
IQVIA Holdings USD 193M 4M Dec/2025
J&J USD 43M 25M Mar/2026
Medtronic USD 181M 0 Dec/2025
Merit Medical Systems USD 6.36M 390K Dec/2025
Neogen USD 13.9M 356K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Quidel USD 5.68B 5.63B Sep/2025
Repligen USD 5.5M 81K Dec/2025
Rockwell Medical USD 232K 199K Jun/2024
Solventum Corp USD 51M 13.92B Dec/2025
STAAR Surgical USD 800K 799K Sep/2025
Terumo JPY 463M 445M Dec/2025
West Pharmaceutical Services USD 1.9M 1.7M Mar/2026